Tovecimig drug page Clinical trials

Trials with Tovecimig

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
25Planned patients

Showing 1–1 of 1

Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
Not yet recruiting Phase 2 25 patients NCT07662031

This is an open-label Phase 2 study to evaluate the safety and efficacy of Tovecimig combined with FOLFIRI in patients who have received one prior line of therapy for advanced or metastatic colorectal cancer (CRC).

United States Aug 2026 – Aug 2032 Interventional